Enerion tab. p / o 200mg # 20
Package quantity, pcs:
twenty
60
Scope of the medicinal product
Neurology, psychiatry
Release form
Tablet
Manufacturer country
France
Package quantity, pcs
twenty
Scope of application
Neurology
,
Psychiatry
Release form
Film-coated tablets
Packaging
20 pcs.
pharmachologic effect
Enerion is a synthetic compound similar in structure to thiamine, in comparison with which the molecule has an open thiazole ring, an additional disulfide bond, and a lipophilic ester.
Thanks to this modification, sulbutiamine is highly soluble in fats, is rapidly absorbed from the gastrointestinal tract and easily penetrates the BBB
unlike thiamine, it is able to accumulate in the cells of the reticular formation, hippocampus and dentate gyrus, as well as Purkinje cells and glomeruli of the granular layer of the cerebellar cortex.
Against the background of Enerion's intake, coordination of movement improves and resistance to physical exertion increases, the resistance of the structures of the cerebral cortex to repeated anoxia increases.
The drug is effective in the symptomatic treatment of functional asthenia.
Pharmacokinetics
Sulbutiamine is rapidly absorbed, Cmax of the drug in the blood plasma is reached within 1–2 hours after administration.
T1 / 2 - about 5 hours.
The drug is excreted in the urine.
Indications
Symptomatic treatment of functional asthenia.
Contraindications
Hypersensitivity to any component of Enerion.
With caution: persons under 18 years of age (the drug is not recommended due to the lack of clinical data).
Application during pregnancy and lactation
According to the results of clinical studies, the drug does not affect the development of the fetus.
However, due to the lack of sufficient clinical data, Enerion is not recommended to be taken during pregnancy, as well as during breastfeeding, because
it is currently unknown whether sulbutiamine is able to pass into breast milk.
special instructions
The excipients of Enerion's preparation include lactose monohydrate.
As a result, this drug is not recommended for people with lactose deficiency, galactosemia or glucose / galactose malabsorption syndrome.
Impact on the ability to drive a car and perform work requiring a high speed of psychomotor reactions.
Does not affect.
Structure
1 coated tablet contains:
active substance: sulbutiamine 200 mg,
excipients: corn starch - 12 mg
dried starch paste - 40 mg
glucose (dextrose) anhydrous - 20 mg
lactose monohydrate - 65.5 mg
magnesium stearate - 3.5 mg
talc - 9 mg,
shell: sodium bicarbonate - 0.603 mg
sodium carboxymethyl cellulose - 0.556 mg
white beeswax - 0.201 mg
titanium dioxide (E171) - 8.43 mg
ethyl cellulose - 0.485 mg
Sunset" yellow (Sunset yellow FCF, E110) - 3 mg
glycerol monooleate - 0.242 mg
polysorbate 80 - 0.302 mg
povidone - 0.692 mg
sucrose - 106.956 mg
anhydrous colloidal silicon dioxide (Aerosil 130) - 0.404 mg, talc - 28.21 mg
Method of administration and dosage
Inside.
Enerion is recommended for use only in adult patients.
The daily dose is 2-3 tablets (400-600 mg) in 2 divided doses (during breakfast and lunch).
The duration of treatment should not exceed 4 weeks.
Side effects
Allergic reactions (the presence in the composition of the dye "Sunset" yellow), digestive disorders, neuropsychiatric reactions (tremor, headache, agitation, general malaise).
Overdose
Symptoms: agitation with symptoms of euphoria and tremors of the extremities are transient and do not require special treatment.
Storage conditions
At a temperature not exceeding 25 ° C, out of the reach of children.
Shelf life
3 years.
Active substance
Sulbutiamine
Name ENG
ENERION
Clinical and pharmacological group
A drug that regulates metabolic processes in the central nervous system
ATX code
Sulbutiamine
Dosage
200mg
Structure
1 coated tablet contains: active substance: sulbutiamine 200 mg auxiliary substances: corn starch - 12 mg
dried starch paste - 40 mg
glucose (dextrose) anhydrous - 20 mg
lactose monohydrate - 65.5 mg
magnesium stearate - 3.5 mg
talc - 9 mg, shell: sodium bicarbonate - 0.603 mg
sodium carboxymethyl cellulose - 0.556 mg
white beeswax - 0.201 mg
titanium dioxide (E171) - 8.43 mg
ethyl cellulose - 0.485 mg
"Sunset" yellow (Sunset yellow FCF, E110) - 3 mg
glycerol monooleate - 0.242 mg
polysorbate 80 - 0.302 mg
povidone - 0.692 mg
sucrose - 106.956 mg
anhydrous colloidal silicon dioxide (Aerosil 130) - 0.404 mg, talc - 28.21 mg
Indications
Symptomatic treatment of functional asthenia.
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 3 years
INN / Active ingredient
Sulbutiamine
Specifications
Scope of the medicinal product
Neurology, psychiatry
Release form
Tablet
Manufacturer country
France
Package quantity, pcs
twenty
Scope of application
Neurology
,
Psychiatry
Minimum age from
18 years
Way of introduction
Through the mouth
Vacation conditions
Without recipe
Brand name
Servier
The amount of the dosage form in the primary package
10 pieces.
Primary packaging type
Blister
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
An agent that regulates metabolic processes in the central nervous system
Anatomical and therapeutic characteristics
A11DA02 Sulbutiamine
Dosage form
Film-coated tablets
The target audience
Adult
Dosage (volume) of the substance in the preparation
1 tablet contains: sulbutiamine 200 mg
Expiration date in days
1095
Package weight, g
25
Category
:
Mental strain
,
Memory impairment
,
Neuroprotective agents
,
Nootropic drugs
Mode of application
:
Inside.
The drug Enerion is recommended for use only in adult patients. < br> The daily dose is 2-3 tablets (400-600 mg) in 2 divided doses (with breakfast and lunch).
The duration of treatment should not exceed 4 weeks.
Information on technical characteristics, delivery set, country of manufacture "